Intracoronary Angiotensin II Potentiates Coronary Sympathetic Vasoconstriction in Humans
Authors:
- 1 July 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (1) , 148-153
Abstract
BackgroundIn humans with coronary artery disease, ACE inhibition attenuates coronary sympathetic vasoconstriction. Whether this is due to removal of angiotensin (Ang) II production or to a reduced bradykinin breakdown, however, is unknown.Methods and ResultsIn eight normotensive patients with angiographic evidence of mild left coronary artery lesions (≤50%), mean arterial pressure (MAP, intra-arterial catheter), heart rate (HR, ECG lead), coronary sinus blood flow (CBF, thermodilution method), and coronary vascular resistance (CVR, ratio between MAP and CBF) were measured before and during a 15-minute left intracoronary infusion of Ang II at a dose that had no direct coronary or systemic vasomotor effects. The same measurements were made before and during a 15-minute infusion of saline. A 2-minute cold pressor test (CPT) and a 45-second diving were performed at the end of either infusion period. These maneuvers were used because their coronary vasomotor effects are abolished by phentolamine and thus depend on sympathetic activation. During saline infusion, both CPT and diving caused a marked increase in MAP. HR increased with CPT and fell with diving. CBF increased in parallel to the MAP increase, with little change in CVR. The MAP and HR responses were similar during Ang II infusion, which, however, caused either no change or a reduction in CBF with a consequent marked increase in CVR with both CPT and diving. In four additional patients, the diameter of the stenotic vessels remained unchanged during the CPT performed under saline and Ang II infusion.ConclusionsAng II markedly enhances sympathetic influences on coronary circulation in humans, presumably by acting at the arteriolar level. This may explain the blunting effect of ACE inhibition on sympathetic coronary vasoconstriction in patients with coronary artery disease.Keywords
This publication has 19 references indexed in Scilit:
- Effects of Early Angiotensin-Converting Enzyme Inhibition in a Pig Model of Myocardial Ischemia and ReperfusionJournal of Cardiovascular Pharmacology, 1992
- Interaction Between the Renin-Angiotensin-Aldosterone and Sympathetic Nervous SystemsJournal of Cardiovascular Pharmacology, 1992
- Mechanisms of angina pectoris in syndrome XJACC, 1991
- EndothelinJournal of Cardiovascular Pharmacology, 1991
- Interaction Between Sympathetic and Renin-angiotensin SystemJournal Of Hypertension, 1984
- Modulation of Noradrenaline Release in the Pithed RabbitJournal of Cardiovascular Pharmacology, 1984
- Effects of angiotensin II on the cardiac responses to sympathetic nerve stimulation in dogs.Hypertension, 1983
- Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture.Hypertension, 1979
- Facilitation of cardiac sympathetic function by angiotensin II: Role of presynaptic angiotensin receptorsEuropean Journal of Pharmacology, 1978
- The use of single plane angiocardiograms for the calculation of left ventricular volume in manAmerican Heart Journal, 1968